에서 실시간으로 운영 중이에요! 자세히 알아보기
64.00 USD
-2.68
4.02%
장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT
프리마켓
시간외 거래
62.50
-1.50
2.34%
1일
-4.02%
5일
1.14%
1개월
19.51%
3개월
58.65%
6개월
185.46%
연초 이후
234.38%
1년
326.95%
5년
-9.83%
10년
1,562.34%
 

소개: CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

직원 수: 765

뉴스

긍정적
중립
부정적
투자 심리 3개월
긍정적 47.6%
중립 42.9%
부정적 9.5%
중립
Business Wire
어제
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report financial results for the third quarter 2026 after market close on Thursday, October 29, 2026. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast of the conference call can be accessed on the Events & Presentations section of C.
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
긍정적
Zacks Investment Research
21일 전
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
부정적
Benzinga
23일 전
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save taxpayers an estimated $1 billion annually.
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
긍정적
Zacks Investment Research
23일 전
5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
Five stocks stand out for high efficiency, with strong receivables, asset, inventory and operating margin metrics.
5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
긍정적
Zacks Investment Research
지난달
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for a possible rate hike.
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
중립
Zacks Investment Research
지난달
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
COCO, CHEF, ASMB and CDNA stand out as four defensive picks amid volatility induced by rising oil prices and Middle East tensions.
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
부정적
Zacks Investment Research
지난달
Are Medical Stocks Lagging CareDx (CDNA) This Year?
Here is how CareDx (CDNA) and Concentra Group (CON) have performed compared to their sector so far this year.
Are Medical Stocks Lagging CareDx (CDNA) This Year?
긍정적
Zacks Investment Research
지난달
CareDx (CDNA) is a Great Momentum Stock: Should You Buy?
Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.
CareDx (CDNA) is a Great Momentum Stock: Should You Buy?
중립
Zacks Investment Research
지난달
Zacks Industry Outlook CareDx, BrightSpring and PACS
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
Zacks Industry Outlook CareDx, BrightSpring and PACS
긍정적
Zacks Investment Research
지난달
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
Lightweight Charts™를 사용해 가격 차트를 구현했어요.